Has the Real MIS Revolution Finally Arrived?
Robotics, or computer-enhanced surgery, still has its skeptics. But a small group of start-up device companies are pushing forward, claiming that they represent a radically new--and better--way to do surgery. The dilemma for the small companies: to sell the concept behind robotics while, at the same time, competitively positioning their individual offerings.
You may also be interested in...
Tired of fighting each other in court, the two leading robotics companies have decided to render their IP differences moot through a merger.
Amgen detailed plans for increasing sales of drugs acquired in its Horizon transaction and outlined growth opportunities in its R&D pipeline during a rare disease showcase.
Deborah Autor will build on Healthcare Innovation Catalysts’ cross-functional technical expertise, furthering its role as an advisor in the private and public sectors as its first CEO.